Based on our findings, we now re-define the IL-1β transgenic mouse as a unique dual model that can be utilized to simultaneously study both inflammation-driven ESCC (plus oral SCC) and GEJ metaplasia/adenocarcinoma. Here, IL1B is linked to esophageal squamous cell carcinoma.